docetaxel
sanofi,aventis
['prostate', 'docetaxel']
results being presented today by #asco2022 for the stopcap collaboration show that not all men with #metastatic prostate cancer benefit from #docetaxel chemotherapy. here s a of the main results 
The MRC CTU @UCL works on answering internationally important questions in cancer, infections & neurodegenerative diseases, and improving trial methodology.